Yali Liu
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 8
- Clinical Biochemistry top 5%
- Cancer Research top 10%
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 8
-
- Pneumonia and Respiratory Infections 8
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 7
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- Hepatitis C virus research 7
-
- Streptococcal Infections and Treatments 6
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yali Liu
55 papers receiving 833 citations
Peers
Comparison fields: 5 of 94
- Molecular Medicine 88
- Clinical Biochemistry 102
- Applied Microbiology and Biotechnology 29
- Cancer Research 182
- Infectious Diseases 201
Countries citing papers authored by Yali Liu
This map shows the geographic impact of Yali Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Liu more than expected).
Fields of papers citing papers by Yali Liu
This network shows the impact of papers produced by Yali Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Liu. The network helps show where Yali Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yali Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 32 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 23 | |
| 15 | 2017 | 0 | |
| 16 | 2017 | 46 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 2 | |
| 19 | 2013 | 23 | |
| 20 | 1995 | 11 |
About Yali Liu
Yali Liu is a scholar working on Molecular Medicine, Microbiology and Epidemiology, having authored 57 papers that have together received 844 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Pneumonia and Respiratory Infections (8 papers), Antibiotic Resistance in Bacteria (8 papers), Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers), Streptococcal Infections and Treatments (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Molecular Medicine (88 citations), Clinical Biochemistry (102 citations) and Applied Microbiology and Biotechnology (29 citations). Yali Liu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hua Zhu, Xiaowei Dai, Chuan Qin, Yanfeng Xu, Xiaoying Wang, Chunmei Ma, Lan Huang, Lianfeng Zhang, Peng Liu and Yingchun Xu. Their work appears in journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.